Jyong BiotechMENS +5.52%10 Market Cap is $163.31 Mil as of Jul. 02, 2026. GuruFocus rates MENS with a GF Score™ of 10/100. The stock has 3 warning signs investors should review. Among 1,427 Biotechnology companies, Jyong Biotech ranks better than 53.61% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Jyong Biotech's share price for the quarter that ended in Dec. 2025 was $3.95. Jyong Biotech's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 74.23 Mil. Therefore, Jyong Biotech's market cap for the quarter that ended in Dec. 2025 was $293.22 Mil.
Jyong Biotech's quarterly market cap
increased
from Dec. 2024 ($0.00 Mil) to Jun. 2025 ($630.99 Mil) but then
declined
from Jun. 2025 ($630.99 Mil) to Dec. 2025 ($293.22 Mil).
Jyong Biotech's annual market cap
stayed the same
from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then
increased
from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($293.22 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Jyong Biotech's Enterprise Value for Today is $180.69 Mil.
Jyong Biotech (NAS:MENS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Jyong Biotech Market Cap Related Terms
Jyong Biotech Market Cap Historical Data
* Premium members only.
The historical data trend for Jyong Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Jyong Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jyong Biotech Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jyong Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Jyong Biotech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Jyong Biotech's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jyong Biotech (MENS) has a Market Cap of $163.31 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Jyong Biotech and its competitors. According to the industry distribution chart, Jyong Biotech ranks #662 out of 1427 companies in the Biotechnology industry, placing it in the top 46.4%.
Is Jyong Biotech's Market Cap too high?
Jyong Biotech's current Market Cap is $163.31 Mil. The Biotechnology industry median Market Cap is 119.04. Jyong Biotech's value of $163.31 Mil is 37.2% above this industry median. Based on the distribution chart, Jyong Biotech ranks #662 out of 1427 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Jyong Biotech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Jyong Biotech's Market Cap compare to ENLV and CNTB?
According to the Biotechnology industry distribution chart, Jyong Biotech ranks #662 out of 1427 companies for Market Cap. This puts Jyong Biotech in the upper half of its industry. The industry median Market Cap is 119.04. Jyong Biotech's value of $163.31 Mil is 37.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.04, based on 1,427 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jyong Biotech's current Market Cap of $163.31 Mil is 37.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Jyong Biotech and its competitors. For the Biotechnology industry, the median Market Cap is 119.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jyong Biotech's current Market Cap is $163.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jyong Biotech stock overvalued right now?
Jyong Biotech (MENS) has a current Market Cap of $163.31 Mil. The current Market Cap is $163.31 Mil and 37.2% above the Biotechnology industry median of 119.04. Jyong Biotech's overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Jyong Biotech (MENS), the current Market Cap is $163.31 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.
10GF Score
Get the complete analysis for MENS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MENS has been successfully added to your 